Evidence map›Paper›PMID 35995938›Full record

ArticlePediatric research2023

Neurometabolic changes in neonates with congenital heart defects and their relation to neurodevelopmental outcome.

Céline Steger, Maria Feldmann, Julia Borns, Cornelia Hagmann, Beatrice Latal, Ulrike Held, András Jakab, Ruth O'Gorman Tuura, Walter Knirsch

Open access · hybridAbstract read
In one paragraph

Article in Pediatric research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Céline StegerCenter for MR-Research, University Children's Hospital, Zurich, Switzerland.
Maria FeldmannChildren's Research Center, University Children's Hospital, Zürich, Switzerland.
Julia BornsPediatric Cardiology, Pediatric Heart Center, Department of Surgery, University Children's Hospital, Zürich, Switzerland.
Cornelia HagmannChildren's Research Center, University Children's Hospital, Zürich, Switzerland.
Beatrice LatalChildren's Research Center, University Children's Hospital, Zürich, Switzerland.
Ulrike HeldUniversity of Zurich, Zurich, Switzerland.
András JakabCenter for MR-Research, University Children's Hospital, Zurich, Switzerland.
Ruth O'Gorman Tuura *Center for MR-Research, University Children's Hospital, Zurich, Switzerland.
Walter Knirsch *Pediatric Cardiology, Pediatric Heart Center, Department of Surgery, University Children's Hospital, Zürich, Switzerland. walter.knirsch@kispi.uzh.ch.ORCID http://orcid.org/0000-0002-8741-3929
University of Zurich · CHUniversity Hospital of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAltered neurometabolite ratios in neonates undergoing cardiac surgery for congenital heart defects (CHD) may serve as a biomarker for altered brain development and neurodevelopment (ND).

methodsWe analyzed single voxel 3T PRESS H

resultsWhite matter NAA/Cho ratios were lower in CHD neonates compared to healthy controls (group beta estimate: -0.26, std. error 0.07, 95% CI: -0.40 - 0.13, p value <0.001, FDR corrected p value = 0.010). We found no correlation between pre- or postoperative white matter NAA/Cho with ND outcome while controlling for socioeconomic status and CHD diagnosis.

conclusionReduced white matter NAA/Cho in CHD neonates undergoing cardiac surgery may reflect a delay in brain maturation. Further long-term MRS studies are needed to improve our understanding of the clinical impact of altered metabolites on brain development and outcome. IMPACT: NAA/Cho was reduced in the white matter, but not the gray matter of CHD neonates compared to healthy controls. No correlation to the 1-year neurodevelopmental outcome (Bayley-III) was found. While the rapid change of NAA/Cho with age might make it a sensitive marker for a delay in brain maturation, the relationship to neurodevelopmental outcome requires further investigation.

Indexed as

Cerebral CortexHeart Defects, CongenitalAspartic AcidBrainCholineCreatineGlutamic AcidHumansInfantInfant, NewbornMagnetic Resonance SpectroscopyAspartic AcidCholineCreatineGlutamic Acid

Identifiers

PMID35995938
PMCPMC10172141
OpenAlexW4292608696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.